← Open Payments lookup

ROSALINE DURING: Open Payments

NPI 1699476119 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$643 in 25 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $24 · 2025 $643

Food & beverage: $643
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$147
Vanda Pharmaceuticals Inc.6$122
Alkermes, Inc.4$86
ABBVIE INC.3$68
Neurocrine BioSciences, Inc.2$57
Lundbeck LLC2$49
Teva Pharmaceuticals USA, Inc.2$40
Corium, LLC2$39
E.R. Squibb & Sons, L.L.C.1$21
Otsuka America Pharmaceutical, Inc.1$14

Products named: CAPLYTA, HETLIOZ, ARISTADA, VRAYLAR, REXULTI, INGREZZA, Azstarys, AUSTEDO XR.

Industry payments across NC — which companies pay providers there.